Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 179 articles: HTML format

Single Articles

June 2025
1. HASSAN IN, Ashraf H, Hasan A
   Sudan conflict: impact on interrupted care after acute myocardial infarction.
   Eur Heart J. 2025 Jun 12:ehaf313. doi: 10.1093.
   PubMed    
   
   
   
2. ARENAS-MONTES J, Alcala-Diaz JF, Garcia-Fernandez H, Gutierrez-Mariscal FM, et al
   A microbiota pattern associated with cardiovascular events in secondary prevention: the CORDIOPREV study.
   Eur Heart J. 2025;46:2104-2115.
   PubMed     Abstract available
   
   
   
3. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
   Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
   Eur Heart J. 2025;46:2052-2062.
   PubMed     Abstract available
   
   
   
4. MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al
   Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis.
   Eur Heart J. 2025;46:2092-2100.
   PubMed     Abstract available
   
   
   May 2025
5. PROCOPI N, Zeitouni M, Kerneis M, Cayla G, et al
   Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AbetaYSS trial.
   Eur Heart J. 2025 May 22:ehaf170. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. CLELAND JGF
   Staring into the AbetaYSS: how many pills and for how long after myocardial infarction?
   Eur Heart J. 2025 May 22:ehaf226. doi: 10.1093.
   PubMed    
   
   
   
7. COYLE M, McEvoy JW
   Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction.
   Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093.
   PubMed    
   
   
   
8. WANG J, Verkerk AO, Wilders R, Zhang Y, et al
   SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
   Eur Heart J. 2025;46:1747-1762.
   PubMed     Abstract available
   
   
   
9. PERRY CGR, Sweeney G
   Targeting mitochondrial fission for the treatment of myocardial infarction.
   Eur Heart J. 2025 May 6:ehaf296. doi: 10.1093.
   PubMed    
   
   
   
10. OIKONOMOU G, Cheng K, Mohiaddin RH
    CMR: a gatekeeper before ICA in a stable non ST-elevation myocardial infarction patient with severely impaired LV function.
    Eur Heart J. 2025 May 6:ehaf300. doi: 10.1093.
    PubMed    
    
    
    
11. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    PubMed     Abstract available
    
    
    
12. WEYRICH M, Zewinger S, Sarakpi T, Rasper T, et al
    Mosaic loss of Y chromosome and mortality after coronary angiography.
    Eur Heart J. 2025;46:1603-1616.
    PubMed     Abstract available
    
    
    
13. ZHANG Q, Li H, Zhuang T, Xu L, et al
    CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9 pathway.
    Eur Heart J. 2025;46:1645-1658.
    PubMed     Abstract available
    
    
    April 2025
14. CREA F
    Focus on heart failure: sex-related differences, new light shed on SGLT2i mechanism of action, and heart failure after myocardial infarction.
    Eur Heart J. 2025;46:1457-1461.
    PubMed    
    
    
    
15. MOLLER JE, Thiele H, Morrow D, Kjaergaard J, et al
    Mechanical circulatory support: when, how, and for whom.
    Eur Heart J. 2025;46:1480-1492.
    PubMed     Abstract available
    
    
    
16. CHEN J, Zhao J, Fu S
    Addressing sample overlap and meta-analysis imbalances in Mendelian randomization: a critical appraisal of protein targets for myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf186. doi: 10.1093.
    PubMed    
    
    
    
17. TITOVA OE, Yuan S, Larsson SC
    Applying Mendelian randomization to study the relationship between circulating proteins and myocardial infarction.
    Eur Heart J. 2025 Apr 18:ehaf187. doi: 10.1093.
    PubMed    
    
    
    
18. BOUGHANEM H, Herrero-Cervera A, Soehnlein O
    SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction repair.
    Eur Heart J. 2025 Apr 8:ehaf165. doi: 10.1093.
    PubMed    
    
    
    March 2025
19. CHIU IM, Ouyang D
    Acute myocardial infarction diagnosis: impact of artificial intelligence-powered ECG interpretation.
    Eur Heart J. 2025 Mar 25:ehaf142. doi: 10.1093.
    PubMed    
    
    
    
20. SOUZA ACDAH, Troschel AS, Marquardt JP, Hadzic I, et al
    Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse cardiovascular outcomes.
    Eur Heart J. 2025;46:1112-1123.
    PubMed     Abstract available
    
    
    
21. XU Y, Feng T, Huang Y
    Gender-specific associations and circulating proteins in myocardial infarction: potential causal relationships.
    Eur Heart J. 2025 Mar 7:ehaf111. doi: 10.1093.
    PubMed    
    
    
    
22. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Circulating proteins and incident myocardial infarction: appraising sex-specific differences and causality.
    Eur Heart J. 2025 Mar 7:ehaf113. doi: 10.1093.
    PubMed    
    
    
    
23. BOUZID Z, Sejdic E, Martin-Gill C, Faramand Z, et al
    Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome.
    Eur Heart J. 2025;46:943-954.
    PubMed     Abstract available
    
    
    
24. CLAESSEN G, Eijsvogels TMH, Albert CM, Baggish AL, et al
    Coronary atherosclerosis in athletes: emerging concepts and preventive strategies.
    Eur Heart J. 2025;46:890-903.
    PubMed     Abstract available
    
    
    
25. CALAFIORE AM, Prapas S, Gaudino M
    Arterial conduits for coronary bypass grafting: the set-point concept.
    Eur Heart J. 2025;46:922-925.
    PubMed     Abstract available
    
    
    
26. DANG QM, Psaltis PJ, Burgess S, Chandrasekhar J, et al
    The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence.
    Eur Heart J. 2025 Mar 7:ehaf097. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
27. LEE MS, Shin TG, Lee Y, Kim DH, et al
    Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study.
    Eur Heart J. 2025 Feb 24:ehaf004. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. CHEN G, Gan J, Wu F, Zhou Z, et al
    Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by improving mitochondrial bioenergetics.
    Eur Heart J. 2025 Feb 11:ehaf032. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. SQUIRE IB, Sze S
    Prognosis following acute myocardial infarction.
    Eur Heart J. 2025 Feb 10:ehaf056. doi: 10.1093.
    PubMed    
    
    
    
30. ROMAN M, Miksza J, Lai FY, Sze S, et al
    Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study.
    Eur Heart J. 2025;46:535-547.
    PubMed     Abstract available
    
    
    
31. CREA F
    Focus on the extreme of the spectrum: myocardial infarction with no obstructive coronary arteries and ischaemic cardiomyopathy.
    Eur Heart J. 2025;46:399-403.
    PubMed    
    
    
    
32. RASMUSSEN LD, Schmidt SE, Knuuti J, Vrints C, et al
    Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials.
    Eur Heart J. 2025;46:473-483.
    PubMed     Abstract available
    
    
    
33. RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al
    Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome.
    Eur Heart J. 2025;46:424-435.
    PubMed     Abstract available
    
    
    January 2025
34. BUTLER J, Hammonds K, Talha KM, Alhamdow A, et al
    Incident heart failure and recurrent coronary events following acute myocardial infarction.
    Eur Heart J. 2025 Jan 28:ehae885. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. PEDICINO D, Volpe M
    Weekly Journal Scan: A CLEAR message questions the routine use of spironolactone in acute myocardial infarction.
    Eur Heart J. 2025 Jan 21:ehae936. doi: 10.1093.
    PubMed    
    
    
    
36. REEH J, Afzal S, Wulff AB, Nordestgaard BG, et al
    Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years.
    Eur Heart J. 2025 Jan 17:ehae912. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. LIUZZO G, Patrono C
    Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine after acute myocardial infarction.
    Eur Heart J. 2025 Jan 9:ehae897. doi: 10.1093.
    PubMed    
    
    
    
38. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    PubMed     Abstract available
    
    
    
39. BJERKING LH, Skak-Hansen KW, Heitmann M, Hove JD, et al
    Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.
    Eur Heart J. 2025;46:117-128.
    PubMed     Abstract available
    
    
    
40. WENZL FA, Wang P, Arrigo M, Parenica J, et al
    Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score.
    Eur Heart J. 2025;46:38-54.
    PubMed     Abstract available
    
    
    December 2024
41. ZHANG Y, Yu S, Chen Z, Liu H, et al
    Gestational diabetes and future cardiovascular diseases: associations by sex-specific genetic data.
    Eur Heart J. 2024;45:5156-5167.
    PubMed     Abstract available
    
    
    
42. PEDICINO D, Volpe M
    Weekly Journal Scan: The jury is still out on beta-blockers following acute myocardial infarction with preserved ejection fraction after the ABYSS trial.
    Eur Heart J. 2024 Dec 14:ehae858. doi: 10.1093.
    PubMed    
    
    
    
43. CHAPMAN AR, Taggart C, Boeddinghaus J, Mills NL, et al
    Type 2 myocardial infarction: challenges in diagnosis and treatment.
    Eur Heart J. 2024 Dec 10:ehae803. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
44. BACK M, Hofmann R
    Myocardial infarction and low ambient temperature: does presence or absence of stenoses make a difference?
    Eur Heart J. 2024 Nov 28:ehae820. doi: 10.1093.
    PubMed    
    
    
    
45. AI L, de Freitas Germano J, Huang C, Aniag M, et al
    Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.
    Eur Heart J. 2024 Nov 27:ehae782. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. NARAYANAN S, Vuckovic S, Bergman O, Wirka R, et al
    Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification.
    Eur Heart J. 2024 Nov 18:ehae768. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. BENDRISS E, Pasqueron J, Bardon J
    Coronary air embolism causing myocardial infarction following a blunt chest trauma.
    Eur Heart J. 2024 Nov 14:ehae771. doi: 10.1093.
    PubMed    
    
    
    
49. WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al
    Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the SEX-SHOCK score.
    Eur Heart J. 2024;45:4564-4578.
    PubMed     Abstract available
    
    
    
50. ZURIAGA MA, Yu Z, Matesanz N, Truong B, et al
    Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis.
    Eur Heart J. 2024;45:4601-4615.
    PubMed     Abstract available
    
    
    
51. LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al
    Optical coherence tomography predictors of clinical outcomes after stent implantation: the ILUMIEN IV trial.
    Eur Heart J. 2024;45:4630-4643.
    PubMed     Abstract available
    
    
    October 2024
52. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. HUANG J, He Q, Jiang Y, Wong JMJ, et al
    Low ambient temperature and incident myocardial infarction with or without obstructive coronary arteries: a Chinese nationwide study.
    Eur Heart J. 2024 Oct 28:ehae711. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
    Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
    Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
    Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
    Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
    PubMed    
    
    
    
57. LIUZZO G, Patrono C
    Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial infarction receive any benefit from a routine invasive strategy?
    Eur Heart J. 2024 Oct 18:ehae684. doi: 10.1093.
    PubMed    
    
    
    
58. RAJAKULASINGAM R, Ferreira PF, Scott AD, Khalique Z, et al
    Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance.
    Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. CREA F
    Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets.
    Eur Heart J. 2024;45:4141-4144.
    PubMed    
    
    
    
60. TITOVA OE, Yuan S, Byberg L, Baron JA, et al
    Plasma proteome and incident myocardial infarction: sex-specific differences.
    Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. BARTON AK, Lau ES, Gulati M
    Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction.
    Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093.
    PubMed    
    
    
    
62. DESCH S, Zeymer U, Akin I, Behnes M, et al
    Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year results of the ECLS-SHOCK trial.
    Eur Heart J. 2024;45:4200-4203.
    PubMed    
    
    
    
63. WEINTRAUB WS, Boden WE
    Achieving successful prevention of coronary artery disease: a worldwide call to action.
    Eur Heart J. 2024;45:4197-4199.
    PubMed    
    
    
    
64. LUSEBRINK E, Binzenhofer L, Thiele H
    The DanGer Shock trial: a new dawn but much to uncover.
    Eur Heart J. 2024;45:4181-4183.
    PubMed    
    
    
    
65. LUSCHER TF, Thiele H
    Cardiogenic shock: do we need a paradigm shift?
    Eur Heart J. 2024;45:4178-4180.
    PubMed    
    
    
    
66. 
    Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
    PubMed    
    
    
    
67. AJUFO EC, Tedrow UB
    Refining the stratification of sudden cardiac death risk after myocardial infarction-beyond ejection fraction.
    Eur Heart J. 2024 Oct 8:ehae272. doi: 10.1093.
    PubMed    
    
    
    
68. PEEK N, Hindricks G, Akbarov A, Tijssen JGP, et al
    Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.
    Eur Heart J. 2024 Oct 8:ehae326. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. SHIMADA T, Fujisawa N, Otsuka K
    Intracoronary polarimetric signatures of exercise-induced vasospastic angina.
    Eur Heart J. 2024;45:3894.
    PubMed    
    
    
    September 2024
70. XU Y, Li H, Santosa A, Wettermark B, et al
    Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study.
    Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. CREA F
    New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
    Eur Heart J. 2024;45:3299-3302.
    PubMed    
    
    
    
72. BAIREY MERZ CN
    Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure.
    Eur Heart J. 2024;45:3748-3750.
    PubMed    
    
    
    
73. BODEN WE, De Caterina R, Kaski JC, Bairey Merz N, et al
    Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.
    Eur Heart J. 2024;45:3701-3706.
    PubMed     Abstract available
    
    
    
74. VRINTS C, Andreotti F, Koskinas KC, Rossello X, et al
    2024 ESC Guidelines for the management of chronic coronary syndromes.
    Eur Heart J. 2024;45:3415-3537.
    PubMed    
    
    
    
75. NURMOHAMED NS, Min JK, Anthopolos R, Reynolds HR, et al
    Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
    Eur Heart J. 2024;45:3735-3747.
    PubMed     Abstract available
    
    
    
76. VERGALLO R, Liuzzo G
    Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease.
    Eur Heart J. 2024;45:3311-3313.
    PubMed    
    
    
    
77. PEDICINO D, Volpe M
    Weekly Journal Scan: increased incidence of acute myocardial infarction in patients with laboratory-confirmed influenza infection.
    Eur Heart J. 2024 Sep 25:ehae569. doi: 10.1093.
    PubMed    
    
    
    
78. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
    Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
    Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
    Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
    PubMed    
    
    
    
80. BADIMON L, Kiss A, Podesser BK
    Spleen in action for cardioprotection.
    Eur Heart J. 2024;45:3178-3180.
    PubMed    
    
    
    
81. NISHI T, Kume T, Saito Y, Kato K, et al
    Intraplaque haemorrhage, coronary spasm, and resuscitated cardiac arrest in patients with non-obstructive coronary artery disease.
    Eur Heart J. 2024;45:3181-3183.
    PubMed    
    
    
    
82. LIUZZO G, Patrono C
    Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy after drug-eluting stenting in acute coronary syndromes?
    Eur Heart J. 2024;45:3108-3110.
    PubMed    
    
    
    
83. LIEDER HR, Paket U, Skyschally A, Rink AD, et al
    Vago-splenic signal transduction of cardioprotection in humans.
    Eur Heart J. 2024;45:3164-3177.
    PubMed     Abstract available
    
    
    
84. GIBSON CM, Duffy D, Bahit MC, Chi G, et al
    Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
    Eur Heart J. 2024 Sep 2:ehae614. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
    Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
    Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
    Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
    Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al
    Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
    Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. EITEL I, Saraei R, Jurczyk D, Fach A, et al
    Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic Microvascular Obstruction: The REVERSE-FLOW Trial.
    Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. SCHUBERT J, Leosdottir M, Lindahl B, Westerberg J, et al
    Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.
    Eur Heart J. 2024 Sep 1:ehae576. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. VAN DEN BROEK WWA, Ten Berg JM
    The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
    Eur Heart J. 2024;45:3057-3059.
    PubMed    
    
    
    
91. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    PubMed    
    
    
    August 2024
92. ONDRACEK AS, Afonyushkin T, Aszlan A, Taqi S, et al
    Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site-derived extracellular vesicles from myocardial infarction patients.
    Eur Heart J. 2024 Aug 31:ehae584. doi: 10.1093.
    PubMed    
    
    
    
93. GERHARDT T, Landmesser U
    Malondialdehyde-specific natural IgM inhibit NETosis triggered by coronary extracellular vesicles of myocardial infarction patients.
    Eur Heart J. 2024 Aug 31:ehae554. doi: 10.1093.
    PubMed    
    
    
    
94. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
95. 
    Correction to: Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
    Eur Heart J. 2024 Aug 30:ehae581. doi: 10.1093.
    PubMed    
    
    
    
96. MCEVOY JW, Jennings C, Kotseva K, De Bacquer D, et al
    Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study.
    Eur Heart J. 2024 Aug 30:ehae558. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. TARDIF JC, Ouellette K, Boulet J
    Colchicine improves outcomes in coronary disease, but will it in heart failure?
    Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093.
    PubMed    
    
    
    
98. MAHAFFEY KW, Tuttle KR, Arici M, Baeres FMM, et al
    Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial.
    Eur Heart J. 2024 Aug 30:ehae613. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. CREA F
    Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
    Eur Heart J. 2024;45:2795-2799.
    PubMed    
    
    
    
100. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
     Coronary artery disease management in older adults: revascularization and exercise training.
     Eur Heart J. 2024;45:2811-2823.
     PubMed     Abstract available
     
     
     
101. CREA F
     Heart failure and ischaemic heart disease: new challenges and opportunities.
     Eur Heart J. 2024;45:2681-2685.
     PubMed    
     
     
     
102. BURZOTTA F, Zito A, Aurigemma C, Romagnoli E, et al
     Fractional flow reserve or optical coherence tomography for angiographically intermediate coronary stenoses: 5-year outcomes in the FORZA trial.
     Eur Heart J. 2024;45:2785-2788.
     PubMed    
     
     
     
103. VOLLEBERG R, Damman P, van Royen N
     Dissection-like appearance of focal catheter-induced vasospasm in intracoronary optical coherence tomography.
     Eur Heart J. 2024;45:2793.
     PubMed    
     
     
     
104. CIULLO A, Li L, Li C, Tsi K, et al
     Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated cardioprotection via a novel gene-methylating mechanism.
     Eur Heart J. 2024;45:2660-2673.
     PubMed     Abstract available
     
     
     
105. PEDICINO D, Vergallo R
     Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
     Eur Heart J. 2024;45:2592-2593.
     PubMed    
     
     
     July 2024
106. LIUZZO G, Patrono C
     Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early vascular events after acute myocardial infarction.
     Eur Heart J. 2024 Jul 26:ehae446. doi: 10.1093.
     PubMed    
     
     
     
107. BESOLA L, Colli A, De Caterina R
     Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
     Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. KANG J, Yun J, Park KW, Park M, et al
     Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
     Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. CREA F
     Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
     Eur Heart J. 2024;45:2463-2467.
     PubMed    
     
     
     
110. GIANNITSIS E, Frey N, Katus HA
     Accelerated high sensitivity troponin diagnostics: ready for an even faster pace?
     Eur Heart J. 2024;45:2516-2518.
     PubMed    
     
     
     
111. DIEZ BENAVENTE E, Sakkers TR, van der Harst P, den Ruijter HM, et al
     Atherosclerotic plaque-specific methylation biomarkers in plasma cell-free DNA of female and male patients with coronary artery disease.
     Eur Heart J. 2024;45:2468-2470.
     PubMed    
     
     
     
112. AHMAD Y, Lansky AJ
     Periprocedural myocardial infarction: thresholds of (in)significance.
     Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093.
     PubMed    
     
     
     
113. JURADO-ROMAN A, Agudo-Quilez P
     Tailoring antithrombotic treatment in patients with acute myocardial infarction and cancer: virtue lies in balance.
     Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093.
     PubMed    
     
     
     
114. DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al
     Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
     Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. FIGTREE GA, Gray MP
     Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet.
     Eur Heart J. 2024;45:2407-2409.
     PubMed    
     
     
     
116. ROGER G, Ducrocq G, Mesnier J, Sayah N, et al
     Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.
     Eur Heart J. 2024;45:2396-2406.
     PubMed     Abstract available
     
     
     
117. BEKKI M, Tahara N, Fukumoto Y
     Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
     Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
     PubMed    
     
     
     June 2024
118. SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al
     Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.
     Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. VILAHUR G, Radike M, Badimon L
     Novel cardioprotective approaches in ischaemic heart disease.
     Eur Heart J. 2024;45:2109-2111.
     PubMed    
     
     
     
120. HOLFELD J, Nagele F, Polzl L, Engler C, et al
     Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
     Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al
     Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular In
     Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. PEDICINO D, Volpe M
     Weekly Journal Scan: do we need beta-blockers after myocardial infarction with preserved ejection fraction?
     Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093.
     PubMed    
     
     
     
123. COUGHLAN JJ, Durand R, Byrne RA
     An initial invasive strategy in older patients with non-ST elevation acute coronary syndromes: it is never too late.
     Eur Heart J. 2024;45:2063-2065.
     PubMed    
     
     
     
124. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
     Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
     Eur Heart J. 2024;45:2052-2062.
     PubMed     Abstract available
     
     
     
125. BEERKENS FJ, Bhatt DL
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
     Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
     PubMed    
     
     
     
126. CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al
     Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.
     Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. LIUZZO G, Patrono C
     Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area.
     Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093.
     PubMed    
     
     
     
128. VERGALLO R, Pedicino D
     Weekly Journal Scan: Impella CP in myocardial infarction complicated by cardiogenic shock.
     Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093.
     PubMed    
     
     
     
129. UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al
     How artificial intelligence can assist with ischaemic heart disease.
     Eur Heart J. 2024;45:1866-1868.
     PubMed    
     
     
     May 2024
130. REN J, Bowyer A, Tian DH, Royse C, et al
     Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
     Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
     PubMed     Abstract available
     
     
     
131. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
     Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
     PubMed     Abstract available
     
     
     
132. KWON O, Ahn JH, Koh JS, Park Y, et al
     Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
     Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. CREA F
     The growing role of coronary computed tomography angiography, polygenic risk scores and electronic nudges in the management of ischaemic heart disease.
     Eur Heart J. 2024;45:1769-1773.
     PubMed    
     
     
     
134. NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al
     Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.
     Eur Heart J. 2024;45:1783-1800.
     PubMed     Abstract available
     
     
     
135. HARIK L, Gaudino M
     Coronary angiography and bypass surgery: born together and now going separate ways?
     Eur Heart J. 2024;45:1816-1818.
     PubMed    
     
     
     
136. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
     Coronary bypass surgery guided by computed tomography in a low-risk population.
     Eur Heart J. 2024;45:1804-1815.
     PubMed     Abstract available
     
     
     
137. LEE YJ, Shin S, Kwon SW, Suh Y, et al
     Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.
     Eur Heart J. 2024 May 16:ehae249. doi: 10.1093.
     PubMed     Abstract available
     
     
     
138. DVIR D, Tchetche D, Leon MB, Genereux P, et al
     Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
     Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
139. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
     Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
     Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. CREA F
     Focus on ischaemic heart disease: prevention with colchicine, role of the brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
     Eur Heart J. 2024;45:1577-1581.
     PubMed    
     
     
     
141. TAKAHARA M, Soga Y, Iida O
     Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization.
     Eur Heart J. 2024;45:1634-1643.
     PubMed     Abstract available
     
     
     
142. AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K
     Repurposing of an antiasthmatic drug may reduce NETosis and myocardial ischaemia/reperfusion injury.
     Eur Heart J. 2024;45:1681-1683.
     PubMed    
     
     
     
143. YANG K, Gao R, Chen H, Hu J, et al
     Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
     Eur Heart J. 2024;45:1662-1680.
     PubMed     Abstract available
     
     
     
144. ADLAM D, van Dijk FS, Loeys B
     Genetic testing in patients with unexplained coronary aneurysms or dilation.
     Eur Heart J. 2024;45:1610-1612.
     PubMed    
     
     
     
145. JONES DA, Beirne AM, Kelham M, Wynne L, et al
     Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
     Eur Heart J. 2024;45:1647-1658.
     PubMed     Abstract available
     
     
     
146. XIAO Q, Xu Y, Wang S
     Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
     Eur Heart J. 2024;45:1685.
     PubMed    
     
     
     
147. CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al
     Artificial intelligence-based assessment of built environment from Google Street View and coronary artery disease prevalence.
     Eur Heart J. 2024;45:1540-1549.
     PubMed     Abstract available
     
     
     
148. HEUSCH G, Kleinbongard P
     Cardioprotection research has left its comfort zone.
     Eur Heart J. 2024;45:1568-1570.
     PubMed    
     
     
     
149. VERGALLO R, Patrono C
     Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
     Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
     PubMed    
     
     
     April 2024
150. NGO LTH, Peng Y, Denman R, Yang I, et al
     Long-term outcomes after hospitalization for atrial fibrillation or flutter.
     Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. GALIUTO L, Volpe M
     Weekly journal scan: excess incidence of unexpected health outcomes following myocardial infarction-broader paths for secondary prevention.
     Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093.
     PubMed    
     
     
     
152. BHATT AS, Johansen ND, Modin D, Claggett BL, et al
     Electronic nudges increase influenza vaccination utilization after myocardial infarction: the nationwide NUDGE-FLU implementation trial.
     Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093.
     PubMed    
     
     
     
153. VERGALLO R, Galiuto L
     Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
     Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
     PubMed    
     
     
     
154. CREA F
     The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
     Eur Heart J. 2024;45:1183-1187.
     PubMed    
     
     
     
155. KASKI JC, Al-Lamee R, Boden WE
     The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease.
     Eur Heart J. 2024;45:1201-1204.
     PubMed    
     
     
     
156. AMERI P, Bertero E, Lombardi M, Porto I, et al
     Ischaemic heart disease in patients with cancer.
     Eur Heart J. 2024;45:1209-1223.
     PubMed     Abstract available
     
     
     
157. BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al
     The '10 commandments' for the 2023 ESC Guidelines for the management of acute coronary syndromes.
     Eur Heart J. 2024;45:1193-1195.
     PubMed    
     
     
     
158. CALLEGARI A, Bonnet D, Malekzadeh-Milani S
     Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion.
     Eur Heart J. 2024;45:1285.
     PubMed    
     
     
     
159. WU VC, Yeh JK, Chen SW, Wu CL, et al
     Syphilis and cardiovascular risk: a Taiwanese registry.
     Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. SAYAH N, Bhatt DL, Miller M, Brinton EA, et al
     Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
     Eur Heart J. 2024;45:1173-1176.
     PubMed    
     
     
     March 2024
161. LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al
     Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
     Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093.
     PubMed     Abstract available
     
     
     
162. WYLD M, Webster AC
     Myocardial infarction and stroke in patients with kidney failure: can we do better?
     Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
     PubMed    
     
     
     
163. TSUDA K, Nagamatsu W, Morii I
     A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
     Eur Heart J. 2024;45:1087.
     PubMed    
     
     
     
164. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
     Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
     Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. URSO S, Sadaba R, Dayan V
     Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
     Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
     PubMed    
     
     
     
166. VERGALLO R, Galiuto L
     Weekly journal scan: do biodegradable polymer stents provide a durable benefit in patients with ST-segment elevation myocardial infarction?
     Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093.
     PubMed    
     
     
     
167. GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al
     Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study.
     Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093.
     PubMed     Abstract available
     
     
     
168. CREA F
     Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic targets.
     Eur Heart J. 2024;45:637-641.
     PubMed    
     
     
     
169. JANSEN TPJ, Wentzel JJ, Damman P
     Interplay between coronary bridging and high shear stress in the emergence of coronary vasospasm.
     Eur Heart J. 2024;45:737.
     PubMed    
     
     
     February 2024
170. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
     Human papillomavirus infection and cardiovascular mortality: a cohort study.
     Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
     PubMed     Abstract available
     
     
     
171. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
     Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
     Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2024
172. SENIOR R, Khattar RS
     To test or not to test for ischaemia routinely after percutaneous coronary intervention in diabetic patients: is the jury still out?
     Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093.
     PubMed    
     
     
     
173. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
     Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
174. GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al
     Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
     Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. LI Z, Zhang H, Lin S
     Functionally bicuspid aortic valve leads to myocardial ischaemia.
     Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
     PubMed    
     
     
     December 2023
176. PIRIOU PG, Plessis J, Guerin P
     Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
     Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
     PubMed    
     
     
     November 2023
177. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     
178. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
     Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
     Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
     PubMed     Abstract available
     
     
     
179. KIM H, Kang DY, Lee J, Choi Y, et al
     Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial.
     Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.